Evolving developments in the management of COPD

Subpage image
Loading

Evolving developments in the management of COPD

07 Oct 2019
CLINICAL THEATRE
The increasing number of inhaled drugs and devices, as well as contrasting national guidelines and recommendations for pathways of care, appear to increase the complexity of COPD treatment. In particular, the introduction of LABA/LAMA and ICS/LABA/LAMA combination inhalers, and a desire to reduce the use of inhaled corticosteroids has changed the way that patients are treated. This session aims to evaluate the current evidence for optimising and de-escalating therapy in COPD management guidelines.
Speakers
Toby Capstick, Consultant Pharmacist - Respiratory Medicine - Leeds Teaching Hospitals NHS Trust

In association with

Pfizer

Supported by

Education Partners

Sponsored by

Charity Partner

Official Media Partner


CIG

Official Publications

Digital Media Partner


C+D

Natural Education Partner

Natural Pharmacy Business

Media partners